Skin metastasis of BRCA mutated prostate cancer: A case report and a brief review of literature

Metastatic castration-resistant prostate cancer has a poor prognosis especially when harboring DNA damage repair gene mutations, nevertheless, in the case of pathogenic BRCA gene mutations, PARPi demonstrated a survival benefit and is a validated treatment. Nowadays, there is no data regarding unusu...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Medicine (Baltimore) 2024-10, Vol.103 (41), p.e40016
Hauptverfasser:	Jubran, Salim, Basso, Umberto, Milani, Anna, Erbetta, Elisa, Di Marco, Andrea, Pittarello, Chiara, Cavasin, Nicolò, Lai, Eleonora, Stragliotto, Silvia, Pierantoni, Francesco, Zampiva, Ilaria, Bimbatti, Davide, Maruzzo, Marco
Format:	Artikel
Sprache:	eng
Schlagworte:	BRCA1 Protein - genetics Clinical Case Report Humans Male Mutation Phthalazines - therapeutic use Piperazines - therapeutic use Prostatic Neoplasms, Castration-Resistant - genetics Prostatic Neoplasms, Castration-Resistant - pathology Skin Neoplasms - genetics Skin Neoplasms - pathology Skin Neoplasms - secondary
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!